Similarly, Tregs in CCA have been shown to express these inhibitor markers, like TIGIT, CTLA-4, and the TNFR-related protein superfamily [157], making them more susceptible to the antitumor effect of PD1 blockade. The gene discussed is TIGIT; the disease is cholangiocarcinoma.